[Concentration of insulin-like growth factor I, IGFBP-1 and IGFBP-3 in postmenopausal period].
The aim of our study was to evaluate concentration of IGF I and binding proteins: IGFBP-1 and IGFBP-3 in postmenopausal period. We have found negative correlation between concentration of IGFBP-1 and BMI, especially after hormonal replacement therapy. 2 mg of 17 beta estradiol given orally.
Hadaś
K
K
Kliniki Endokrynologii Ginekologicznej, Instytutu Ginekologii i Połoznictwa, Akademii Medycznej w Poznaniu.
Maciejewska
M
M
Halerz-Nowakowska
B
B
Wiza
M
M
Dydowicz
M
M
Warenik-Szymankiewicz
A
A
D015992:Body Mass Index; D005260:Female; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000097:blood*; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D008593:Menopause / Q000502:physiology*; D008875:Middle Aged
D018970:Insulin-Like Growth Factor Binding Protein 1; D018972:Insulin-Like Growth Factor Binding Protein 3
Stezenie insulinopodobnego czynnika wzrostu pierwszego, IGFBP-1 i IGFBP-3 u kobiet w okresie postmenopauzalnym.